xB3-007 Neurodegeneration

Welcome to the Bioasis Technologies Hub On AGORACOM

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

xB3-007 Neurodegeneration

posted on Jun 27, 2018 10:27AM

xB3-007 Neurodegeneration Program

"Advance Our xB3-007 Program Targeting Neurodegenerative Diseases. We will provide further details on this program going forward based on future developments and progress, as appropriate........Details and status to be reported at a future date...........For the 007 program in neurodegeneration, the Company plans to complete pre-clinical POC (Q4 of 2018) and initiate manufacturing (Q1 of 2019)."

biOasis is keeping this 007 program very quiet. But if pre-clinical proof-of-concept is anticipated to be complete in Q4 2018, then it shouldn't be long until we hear more.